MedPath
HSA Product

POSACONAZOLE SANDOZ GASTRO-RESISTANT TABLETS 100MG

Product approved by Health Sciences Authority (SG)

Basic Information

POSACONAZOLE SANDOZ GASTRO-RESISTANT TABLETS 100MG

TABLET, DELAYED RELEASE

Regulatory Information

SIN15897P

March 9, 2020

Prescription Only

Therapeutic

ORAL

August 10, 2023

June 3, 2025

XJ02AC04

Company Information

NOVARTIS (SINGAPORE) PTE LTD

SANDOZ SINGAPORE PTE. LTD.

Active Ingredients

Posaconazole

Strength: 100.00 mg

© Copyright 2025. All Rights Reserved by MedPath